Utah Medical Products (UTMD) Retained Earnings (2010 - 2026)

Utah Medical Products has reported Retained Earnings for 17 years, with the latest figure at $130.3 million in Q1 2026.

• For the quarter ending Q1 2026, Retained Earnings rose 1.6% year-over-year to $130.3 million; the trailing twelve-month figure through Mar 2026 stood at $130.3 million (up 1.6% YoY), and the FY2025 full-year result was $128.7 million, down 0.5% from the prior year.
• Retained Earnings for Q1 2026 stood at $130.3 million, up from $128.7 million in the prior quarter.
• The five-year high for Retained Earnings was $139.0 million in Q1 2024, with the low at $117.8 million in Q1 2022.
• Average Retained Earnings over 5 years is $129.4 million, with a median of $129.2 million recorded in 2023.
• Year-over-year, Retained Earnings advanced 10.89% in 2023 and retreated 7.76% in 2025.
• Tracing UTMD's Retained Earnings over 5 years: stood at $126.0 million in 2022, then increased by 9.79% to $138.3 million in 2023, then declined by 6.53% to $129.3 million in 2024, then retreated by 0.5% to $128.7 million in 2025, then climbed by 1.25% to $130.3 million in 2026.
• The last three Retained Earnings figures came in at $130.3 million (Q1 2026), $128.7 million (Q4 2025), and $128.0 million (Q3 2025), per Business Quant data.

Peer Comparison